SCHEMBL23273892

SCHEMBL23273892

COc1ccc(CNc2ncnc3c2c(Br)cn3[C@@H]2O[C@H](CO)[C@H]3OC(C)(C)O[C@H]32)c(OC)c1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADORA3 P0DMS8 6/20 0.44
▸ ADORA2A P29274 1/20 0.44
▸ ADORA1 P30542 1/20 0.44
▸ PI4KA P42356 1/20 0.42
▸ PI4K2B Q8TCG2 1/20 0.42
▸ PI4K2A Q9BTU6 1/20 0.42
▸ PI4KB Q9UBF8 1/20 0.42
▸ HTR2B P41595 3/20 0.39
▸ SIGMAR1 Q99720 2/20 0.39
▸ ALDH1A1 P00352 2/20 0.39
▸ CYP1A2 P05177 2/20 0.39
▸ CYP3A4 P08684 2/20 0.39
▸ TSHR P16473 2/20 0.39
▸ CYP2C19 P33261 2/20 0.39
▸ CLK4 Q9HAZ1 2/20 0.39
▸ USP2 O75604 1/20 0.39
▸ CYP2D6 P10635 1/20 0.39
▸ HTR1D P28221 1/20 0.39
▸ TMEM97 Q5BJF2 1/20 0.39
▸ LMNA P02545 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24314227 0.91 ADORA3 (0.44) ADORA3ADORA2AADORA1PI4KAPI4K2B
SCHEMBL29610857 0.88 ADORA3 (0.43) ADORA3ALDH1A1CYP1A2CYP3A4TSHR
SCHEMBL29611653 0.88 ADORA3 (0.43) ADORA3ADORA2AALDH1A1CYP1A2CYP3A4
SCHEMBL24313864 0.88 ADORA3 (0.43) ADORA3ALDH1A1CYP1A2CYP3A4TSHR
SCHEMBL24313565 0.88 ADORA3 (0.43) ADORA3ADORA2AALDH1A1CYP1A2CYP3A4
SCHEMBL24313539 0.88 CYP1A2 (0.36) ADORA3ADORA2AADORA1ALDH1A1CYP1A2
SCHEMBL23312996 0.88 ADORA3 (0.42) ADORA3ADORA2AADORA1PI4KAPI4K2B
SCHEMBL29611607 0.87 ADORA1 (0.54) ADORA3ADORA2AADORA1HTR2BSIGMAR1
SCHEMBL27090409 0.87 ADORA1 (0.54) ADORA3ADORA2AADORA1HTR2BSIGMAR1
SCHEMBL9109338 0.86 ADORA3 (0.46) ADORA3ADORA2AADORA1PI4KAPI4K2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240051985-A1 METTL3 MODULATORS ACCENT THERAPEUTICS INC (US) 2024-02-15 — — US disclosed
EP-4229067-A1 METTL3 MODULATORS Accent Therapeutics, Inc. (US) 2023-08-23 — — EP disclosed
US-20230027361-A1 METTL3 MODULATORS ACCENT THERAPEUTICS, INC. (US) 2023-01-26 — — US disclosed
CN-115298179-A METTL3 modulators 埃克森特治疗公司 2022-11-04 — — CN disclosed
EP-4048674-A2 METTL3 MODULATORS Accent Therapeutics, Inc. (US) 2022-08-31 — — EP disclosed
WO-2021079196-A9 METTL3 MODULATORS ACCENT THERAPEUTICS, INC (US) 2022-07-14 — — WO disclosed
WO-2021079196-A9 METTL3 MODULATORS ACCENT THERAPEUTICS, INC (US) 2022-07-14 — — WO disclosed
WO-2022081739-A1 METTL3 MODULATORS ACCENT THERAPEUTICS, INC. (US) 2022-04-21 — — WO disclosed
WO-2021079196-A2 METTL3 MODULATORS ACCENT THERAPEUTICS, INC (US) 2021-04-29 — — WO disclosed
WO-2021079196-A2 METTL3 MODULATORS ACCENT THERAPEUTICS, INC (US) 2021-04-29 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240051985-A1 METTL3 MODULATORS METTL3, METTL16, METTL14 ADORA3 684/4885ADORA2A 2204/4885ADORA1 2456/4885
US-20230027361-A1 METTL3 MODULATORS METTL3, METTL16, METTL14 ADORA3 729/4885ADORA2A 2166/4885ADORA1 2658/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback